Author

J. Kardos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. de Reynies· 1 shared A. G. Robertson· 1 shared A. Hartmann· 1 shared A. Kamoun· 1 shared A. Poti· 1 shared A. Remenyi· 1 shared A. Zlotta· 1 shared C. P. Dinney· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. de Reynies

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

High throughput competitive fluorescence polarization assay reveals functionalredundancy in the S100 protein family

M. Simon, G. Gogl, P. Ecsedi, G. M. Kovacs, A. Poti, A. Remenyi, J. Kardos, L. Nyitray

The paper uses a high-throughput fluorescence polarization assay to analyze the functional redundancy and interaction patterns of the human S100 protein family.

The FEBS Journal · Jan 3, 2020Peer-reviewedBiochemistry

A consensus molecular classification of muscle-invasive bladder cancer

A. Kamoun, A. de Reynies, Y. Allory, G. Sjodahl, A. G. Robertson, R. Seiler, K. Hoadley, H. Al-Ahmadie, W. Choi, C. S. Groeneveld, M. A. A. Castro, J. Fontugne, P. Eriksson, Q. Mo, J. Kardos, , The Bladder Cancer Molecular Taxonomy Group

The paper identifies six consensus molecular classes of muscle-invasive bladder cancer using transcriptomic data and classification systems, providing a framework for future biomarker validation.

bioRxiv · Apr 27, 2019Cancer Biology